SQZ Biotechnologies Company

SQZ Biotechnologies Companyverified

SQZ

Price:

$0.435

Market Cap:

$12.83M

SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with other immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations wi...[Read more]

Industry

Biotechnology

IPO Date

2020-10-30

Stock Exchange

NYSE

Ticker

SQZ

The PE Ratio as of April 2024 (TTM) for SQZ Biotechnologies Company (SQZ) is -0.20

According to SQZ Biotechnologies Company’s latest financial reports and current stock price. The company's current PE Ratio is -0.20. This represents a change of 335.27% compared to the average of -0.05 of the last 4 quarters.

SQZ Biotechnologies Company (SQZ) Historical PE Ratio (quarterly & annually)

How has SQZ PE Ratio performed in the past?

The mean historical PE Ratio of SQZ Biotechnologies Company over the last ten years is -4.86. The current -0.20 PE Ratio has changed 314.65% with respect to the historical average. Over the past ten years (40 quarters), SQZ's PE Ratio was at its highest in in the December 2022 quarter at 0.17. The PE Ratio was at its lowest in in the March 2018 quarter at -9.92.

Quarterly (TTM)
Annual

Average

-4.86

Median

-3.58

Minimum

-9.92

Maximum

-0.27

SQZ Biotechnologies Company (SQZ) PE Ratio by Quarter and Year

Discovering the peaks and valleys of SQZ Biotechnologies Company PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 14.42%

Maximum Annual PE Ratio = -0.27

Minimum Annual Increase = -92.40%

Minimum Annual PE Ratio = -9.92

Quarterly (TTM)
Annual
YearPE RatioChange
2022-0.27-92.40%
2021-3.5814.42%
2020-3.13-57.52%
2019-7.37-25.67%

SQZ Biotechnologies Company (SQZ) Average PE Ratio

How has SQZ PE Ratio performed in the past?

The current PE Ratio of SQZ Biotechnologies Company (SQZ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-2.33

5-year avg

-4.86

10-year avg

-4.86

SQZ Biotechnologies Company (SQZ) PE Ratio vs. Peers

How is SQZ’s PE Ratio compared to its peers?

SQZ Biotechnologies Company’s PE Ratio is greater than AN2 Therapeutics, Inc. (-1.11), greater than Miromatrix Medical Inc. (-3.41), greater than Inhibikase Therapeutics, Inc. (-0.51), greater than PMV Pharmaceuticals, Inc. (-1.41), greater than Anebulo Pharmaceuticals, Inc. (-6.68), less than Comera Life Sciences Holdings, Inc. (-0.01), greater than SAB Biotherapeutics, Inc. (-0.62), greater than Processa Pharmaceuticals, Inc. (-0.30), greater than Fresh Tracks Therapeutics, Inc. (-0.84), greater than Third Harmonic Bio, Inc. (-23.63), less than Lipella Pharmaceuticals Inc. (0.66), less than Senti Biosciences, Inc. (-0.19), greater than Fennec Pharmaceuticals Inc. (-14.05), greater than Monopar Therapeutics Inc. (-1.14), less than Applied Molecular Transport Inc. (-0.14), greater than Neoleukin Therapeutics, Inc. (-0.98), less than Hillstream BioPharma, Inc. (-0.00), less than Quoin Pharmaceuticals, Ltd. (-0.08), greater than Candel Therapeutics, Inc. (-4.44), greater than Werewolf Therapeutics, Inc. (-6.10), greater than Kezar Life Sciences, Inc. (-0.61), greater than Nuvation Bio Inc. (-8.37),

Build a custom stock screener for SQZ Biotechnologies Company (SQZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SQZ Biotechnologies Company using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SQZ Biotechnologies Company (SQZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SQZ Biotechnologies Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is SQZ Biotechnologies Company's PE Ratio?

How is the PE Ratio calculated for SQZ Biotechnologies Company (SQZ)?

What is the highest PE Ratio for SQZ Biotechnologies Company (SQZ)?

What is the 3-year average PE Ratio for SQZ Biotechnologies Company (SQZ)?

What is the 5-year average PE Ratio for SQZ Biotechnologies Company (SQZ)?

How does the current PE Ratio for SQZ Biotechnologies Company (SQZ) compare to its historical average?